Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r
✍ Scribed by Hansenson, M. ;Lundh, B. ;Hartley-Asp, B. ;Pousette, �.
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 443 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Evodiamine, isolated from a Chinese herbal drug named Wu‐Chu‐Yu, possesses many biological functions. Recently, it has been reported that Wu‐Chu‐Yu exerts an antiproliferative effect on several cancers. Prostate carcinoma initially occurs as an androgen‐dependent tumor and is the second
## BACKGROUND. Although fenretinide (4-HPR) is currently being evaluated in a phase II clinical study for the chemoprevention of prostate cancer [Greenwald et al.: CA 45:31-49, 1995], the mechanism underlying its antineoplastic activity has not been elucidated. METHODS. Androgen-dependent human pr
We have cloned a cDNA from chromosome band 17p13.3, designated as HCAP1 (HCC-associated protein 1, originally named HC56). Database searches revealed that HCAP1 shares most of its open reading frame with GEMIN4. Single nucleotide polymorphism (SNP) screening revealed a high incidence of SNP in the c